Famotidine can cause depression, but it’s rare. The FDA lists depression among the psychiatric side effects reported in clinical trials, alongside anxiety, insomnia, and decreased libido. These reactions are classified as infrequent, and in documented cases, they have been reversible after stopping the medication.
What the FDA Label Says
The official prescribing information for famotidine, updated in October 2025, lists depression under “Nervous System/Psychiatric” adverse reactions observed in clinical trials. It sits alongside seizures, hallucinations, anxiety, decreased libido, insomnia, and drowsiness. The label does not assign a specific percentage to depression, grouping it with reactions that occurred infrequently. That means it showed up in trials but not often enough to calculate a reliable rate.
The label also carries a separate warning about central nervous system reactions, specifically calling out confusion, delirium, hallucinations, disorientation, agitation, seizures, and lethargy in elderly patients and those with moderate to severe kidney impairment. Depression isn’t singled out in the warning section, which suggests it’s considered less common or less severe than those other neuropsychiatric effects.
How Famotidine Could Affect Mood
Famotidine works by blocking histamine receptors in the stomach to reduce acid production. But histamine also plays a role in the brain, where all four types of histamine receptors are active. The brain’s histamine system helps regulate wakefulness, appetite, and mood, so blocking those receptors could theoretically interfere with normal brain chemistry.
The catch is that famotidine doesn’t easily get into the brain. It’s a polar molecule, meaning it doesn’t pass through the blood-brain barrier well. Human studies show that only about 9% of an intravenous dose reaches the brain. For oral doses, which are what most people take, the amount is likely even smaller. This low penetration helps explain why psychiatric side effects are uncommon for most users, but it also means that in certain situations where more of the drug reaches the brain, the risk goes up.
Who Is More Vulnerable
Kidney function is the biggest risk factor. Your kidneys clear famotidine from your body, so when they aren’t working well, the drug builds up in both your blood and your brain. In a study of hemodialysis patients who developed neurological symptoms after receiving famotidine intravenously, the drug concentration in their spinal fluid was roughly three to five times higher than the levels seen in patients without symptoms. Even patients with just mild kidney impairment have shown elevated brain exposure.
Older adults face higher risk for two reasons: kidney function naturally declines with age, and the blood-brain barrier can become more permeable. Case reports of famotidine-related mental status changes have overwhelmingly involved elderly patients, often with some degree of kidney impairment. In one documented case, a 77-year-old man developed confusion, disorientation, and nightmares after switching from another acid reducer to famotidine at a standard dose of 20 mg twice daily.
People who have had brain surgery may also be more susceptible. Research on neurosurgical patients found that the ratio of famotidine in spinal fluid compared to blood was about four times higher than what’s typically reported in people without neurological conditions, regardless of kidney function.
How Quickly Symptoms Resolve
The good news is that psychiatric side effects from famotidine appear to be reversible. In the case of the 77-year-old man mentioned above, his symptoms cleared within two days of stopping the medication. When he restarted it on his own, the symptoms came back, along with visual hallucinations, confirming the drug was the cause. This pattern of quick onset and quick resolution after stopping is consistent across most documented cases.
The FDA label notes that in cases where follow-up information was available, psychiatric disturbances were reversible. No reports describe long-lasting depression specifically caused by famotidine that persisted after discontinuation.
Famotidine vs. Other Acid Reducers
If you’re concerned about depression risk from acid-reducing medications, the comparison with proton pump inhibitors (PPIs) like omeprazole is worth knowing. A population-based study found that PPI use was associated with more than double the odds of depression compared to nonusers (an odds ratio of 2.38). The same study found no association between H2 blockers, the drug class famotidine belongs to, and depression scores. That doesn’t mean famotidine never causes depression, but at a population level, it doesn’t appear to carry the same mood-related risk that PPIs do.
Drug Interactions to Be Aware Of
Famotidine can also amplify the effects of other medications in ways that produce psychiatric symptoms. In one pediatric case, a 10-year-old boy on a mood stabilizer (valproic acid) developed acute altered mental status and increasing drowsiness two days after starting prescription famotidine. The interaction caused his mood stabilizer levels to rise to toxic concentrations. While this isn’t depression per se, it illustrates how famotidine can interact with psychiatric medications and change their effects in your body.
What This Means Practically
For the average person taking over-the-counter famotidine for heartburn or acid reflux, depression is an unlikely side effect. The drug doesn’t reach the brain in large amounts under normal circumstances, and population studies haven’t linked H2 blockers to mood disorders the way they have with PPIs. That said, if you’re elderly, have any degree of kidney disease, or take medications that affect brain chemistry, you’re in a higher-risk category for neuropsychiatric effects including mood changes.
If you’ve noticed new or worsening low mood after starting famotidine, the timeline matters. Symptoms that began within days to a couple of weeks of starting the medication and that don’t have another obvious explanation are worth flagging. Based on case reports, stopping the drug typically resolves psychiatric symptoms within a few days.